51
|
Waalkens AJE, Vansenne F, van der Hout AH, Zutt R, Mourmans J, Tolosa E, de Koning TJ, Tijssen MAJ. Expanding the ADCY5 phenotype toward spastic paraparesis: A mutation in the M2 domain. NEUROLOGY-GENETICS 2018; 4:e214. [PMID: 29473048 PMCID: PMC5820596 DOI: 10.1212/nxg.0000000000000214] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 05/23/2017] [Accepted: 12/13/2017] [Indexed: 01/30/2023]
Affiliation(s)
- Anne J E Waalkens
- Department of Neurology (A.J.E.W., R.Z., M.A.J.T.), and Department of Genetics (F.V., A.H.v.d.H., T.J.d.K.), University Medical Center Groningen, University of Groningen; Department of Pediatrics (J.M.), Deventer Hospital, The Netherlands; and Parkinson's Disease and Movement Disorders Unit (E.T.), Hospital Clinic of Barcelona, Institut Clínic de Neurociències, Barcelona, Spain
| | - Fleur Vansenne
- Department of Neurology (A.J.E.W., R.Z., M.A.J.T.), and Department of Genetics (F.V., A.H.v.d.H., T.J.d.K.), University Medical Center Groningen, University of Groningen; Department of Pediatrics (J.M.), Deventer Hospital, The Netherlands; and Parkinson's Disease and Movement Disorders Unit (E.T.), Hospital Clinic of Barcelona, Institut Clínic de Neurociències, Barcelona, Spain
| | - Annemarie H van der Hout
- Department of Neurology (A.J.E.W., R.Z., M.A.J.T.), and Department of Genetics (F.V., A.H.v.d.H., T.J.d.K.), University Medical Center Groningen, University of Groningen; Department of Pediatrics (J.M.), Deventer Hospital, The Netherlands; and Parkinson's Disease and Movement Disorders Unit (E.T.), Hospital Clinic of Barcelona, Institut Clínic de Neurociències, Barcelona, Spain
| | - Rodi Zutt
- Department of Neurology (A.J.E.W., R.Z., M.A.J.T.), and Department of Genetics (F.V., A.H.v.d.H., T.J.d.K.), University Medical Center Groningen, University of Groningen; Department of Pediatrics (J.M.), Deventer Hospital, The Netherlands; and Parkinson's Disease and Movement Disorders Unit (E.T.), Hospital Clinic of Barcelona, Institut Clínic de Neurociències, Barcelona, Spain
| | - Jeroen Mourmans
- Department of Neurology (A.J.E.W., R.Z., M.A.J.T.), and Department of Genetics (F.V., A.H.v.d.H., T.J.d.K.), University Medical Center Groningen, University of Groningen; Department of Pediatrics (J.M.), Deventer Hospital, The Netherlands; and Parkinson's Disease and Movement Disorders Unit (E.T.), Hospital Clinic of Barcelona, Institut Clínic de Neurociències, Barcelona, Spain
| | - Eduardo Tolosa
- Department of Neurology (A.J.E.W., R.Z., M.A.J.T.), and Department of Genetics (F.V., A.H.v.d.H., T.J.d.K.), University Medical Center Groningen, University of Groningen; Department of Pediatrics (J.M.), Deventer Hospital, The Netherlands; and Parkinson's Disease and Movement Disorders Unit (E.T.), Hospital Clinic of Barcelona, Institut Clínic de Neurociències, Barcelona, Spain
| | - Tom J de Koning
- Department of Neurology (A.J.E.W., R.Z., M.A.J.T.), and Department of Genetics (F.V., A.H.v.d.H., T.J.d.K.), University Medical Center Groningen, University of Groningen; Department of Pediatrics (J.M.), Deventer Hospital, The Netherlands; and Parkinson's Disease and Movement Disorders Unit (E.T.), Hospital Clinic of Barcelona, Institut Clínic de Neurociències, Barcelona, Spain
| | - Marina A J Tijssen
- Department of Neurology (A.J.E.W., R.Z., M.A.J.T.), and Department of Genetics (F.V., A.H.v.d.H., T.J.d.K.), University Medical Center Groningen, University of Groningen; Department of Pediatrics (J.M.), Deventer Hospital, The Netherlands; and Parkinson's Disease and Movement Disorders Unit (E.T.), Hospital Clinic of Barcelona, Institut Clínic de Neurociències, Barcelona, Spain
| |
Collapse
|
52
|
Miyatake S, Koshimizu E, Shirai I, Kumada S, Nakata Y, Kamemaru A, Nakashima M, Mizuguchi T, Miyake N, Saitsu H, Matsumoto N. A familial case of
PDE10A
‐associated childhood‐onset chorea with bilateral striatal lesions. Mov Disord 2017; 33:177-179. [DOI: 10.1002/mds.27219] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2017] [Revised: 09/22/2017] [Accepted: 09/24/2017] [Indexed: 12/16/2022] Open
Affiliation(s)
- Satoko Miyatake
- Department of Human GeneticsYokohama City University Graduate School of MedicineYokohama Kanagawa Japan
- Clinical Genetics DepartmentYokohama City University HospitalYokohama Kanagawa Japan
| | - Eriko Koshimizu
- Department of Human GeneticsYokohama City University Graduate School of MedicineYokohama Kanagawa Japan
| | - Ikuko Shirai
- Department of NeuropediatricsTokyo Metropolitan Neurological HospitalFuchu Tokyo Japan
| | - Satoko Kumada
- Department of NeuropediatricsTokyo Metropolitan Neurological HospitalFuchu Tokyo Japan
| | - Yasuhiro Nakata
- Department of NeuroradiologyTokyo Metropolitan Neurological HospitalFuchu Tokyo Japan
| | - Aiko Kamemaru
- Department of Human GeneticsYokohama City University Graduate School of MedicineYokohama Kanagawa Japan
| | - Mitsuko Nakashima
- Department of Human GeneticsYokohama City University Graduate School of MedicineYokohama Kanagawa Japan
- Department of BiochemistryHamamatsu University School of MedicineShizuoka Japan
| | - Takeshi Mizuguchi
- Department of Human GeneticsYokohama City University Graduate School of MedicineYokohama Kanagawa Japan
| | - Noriko Miyake
- Department of Human GeneticsYokohama City University Graduate School of MedicineYokohama Kanagawa Japan
| | - Hirotomo Saitsu
- Department of Human GeneticsYokohama City University Graduate School of MedicineYokohama Kanagawa Japan
- Department of BiochemistryHamamatsu University School of MedicineShizuoka Japan
| | - Naomichi Matsumoto
- Department of Human GeneticsYokohama City University Graduate School of MedicineYokohama Kanagawa Japan
| |
Collapse
|
53
|
Abstract
INTRODUCTION Chorea is defined as jerk-like movements that move randomly from one body part to another. It is due to a variety of disorders and although current symptomatic therapy is quite effective there are few etiology- or pathogenesis-targeted therapies. The aim of this review is to summarize our own experience and published evidence in the treatment of chorea. Areas covered: After evaluating current guidelines and clinical practices for chorea of all etiologies, PubMed was searched for the most recent clinical trials and reviews using the term 'chorea' cross referenced with specific drug names. Expert commentary: Inhibitors of presynaptic vesicular monoamine transporter type 2 (VMAT2) that cause striatal dopamine depletion, such as tetrabenazine, deutetrabenazine, and valbenazine, are considered the treatment of choice in patients with chorea. Some clinicians also use dopamine receptor blockers (e.g. antipsychotics) and other drugs, including anti-epileptics and anti-glutamatargics. 'Dopamine stabilizers' such as pridopidine and other experimental drugs are currently being investigated in the treatment of chorea. Deep brain stimulation is usually reserved for patients with disabling chorea despite optimal medical therapy.
Collapse
Affiliation(s)
- H Bashir
- a Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology , Baylor College of Medicine , Houston , TX , USA
| | - J Jankovic
- a Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology , Baylor College of Medicine , Houston , TX , USA
| |
Collapse
|
54
|
Abstract
Purpose of Review Hyperkinetic movement disorders can manifest alone or as part of complex phenotypes. In the era of next-generation sequencing (NGS), the list of monogenic complex movement disorders is rapidly growing. This review will explore the main features of these newly identified conditions. Recent Findings Mutations in ADCY5 and PDE10A have been identified as important causes of childhood-onset dyskinesias and KMT2B mutations as one of the most frequent causes of complex dystonia in children. The delineation of the phenotypic spectrum associated with mutations in ATP1A3, FOXG1, GNAO1, GRIN1, FRRS1L, and TBC1D24 is revealing an expanding genetic overlap between epileptic encephalopathies, developmental delay/intellectual disability, and hyperkinetic movement disorders,. Summary Thanks to NGS, the etiology of several complex hyperkinetic movement disorders has been elucidated. Importantly, NGS is changing the way clinicians diagnose these complex conditions. Shared molecular pathways, involved in early stages of brain development and normal synaptic transmission, underlie basal ganglia dysfunction, epilepsy, and other neurodevelopmental disorders.
Collapse
Affiliation(s)
- Miryam Carecchio
- Molecular Neurogenetics Unit, IRCCS Foundation Carlo Besta Neurological Institute, Via L. Temolo 4, 20126, Milan, Italy.,Department of Pediatric Neurology, IRCCS Foundation Carlo Besta Neurological Institute, Via Celoria 11, 20131, Milan, Italy.,Department of Medicine and Surgery, PhD Programme in Molecular and Translational Medicine, Milan Bicocca University, Via Cadore 48, 20900, Monza, Italy
| | - Niccolò E Mencacci
- Department of Neurology, Northwestern University, Feinberg School of Medicine, Chicago, IL, 60611, USA. .,Department of Molecular Neuroscience, UCL Institute of Neurology, London, WC1N 3BG, UK.
| |
Collapse
|
55
|
Esposito S, Carecchio M, Tonduti D, Saletti V, Panteghini C, Chiapparini L, Zorzi G, Pantaleoni C, Garavaglia B, Krainc D, Lubbe SJ, Nardocci N, Mencacci NE. A PDE10A
de novo mutation causes childhood-onset chorea with diurnal fluctuations. Mov Disord 2017; 32:1646-1647. [DOI: 10.1002/mds.27175] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2017] [Revised: 08/17/2017] [Accepted: 08/23/2017] [Indexed: 11/10/2022] Open
Affiliation(s)
- Silvia Esposito
- Department of Paediatric Neuroscience; IRCCS Foundation Carlo Besta Neurological Institute; Milan Italy
| | - Miryam Carecchio
- Department of Paediatric Neuroscience; IRCCS Foundation Carlo Besta Neurological Institute; Milan Italy
- Molecular Neurogenetics Unit; IRCCS Foundation Carlo Besta Neurological Institute; Milan Italy
- Department of Medicine and Surgery; PhD Programme in Molecular and Translational Medicine, Milan Bicocca University; Monza Italy
| | - Davide Tonduti
- Department of Paediatric Neuroscience; IRCCS Foundation Carlo Besta Neurological Institute; Milan Italy
| | - Veronica Saletti
- Department of Paediatric Neuroscience; IRCCS Foundation Carlo Besta Neurological Institute; Milan Italy
| | - Celeste Panteghini
- Molecular Neurogenetics Unit; IRCCS Foundation Carlo Besta Neurological Institute; Milan Italy
| | - Luisa Chiapparini
- Neuroradiology Department; IRCCS Foundation Carlo Besta Neurological Institute; Milan Italy
| | - Giovanna Zorzi
- Department of Paediatric Neuroscience; IRCCS Foundation Carlo Besta Neurological Institute; Milan Italy
| | - Chiara Pantaleoni
- Department of Paediatric Neuroscience; IRCCS Foundation Carlo Besta Neurological Institute; Milan Italy
| | - Barbara Garavaglia
- Molecular Neurogenetics Unit; IRCCS Foundation Carlo Besta Neurological Institute; Milan Italy
| | - Dimitri Krainc
- Department of Neurology; Northwestern University, Feinberg School of Medicine; Chicago Illinois USA
| | - Steven J. Lubbe
- Department of Neurology; Northwestern University, Feinberg School of Medicine; Chicago Illinois USA
| | - Nardo Nardocci
- Department of Paediatric Neuroscience; IRCCS Foundation Carlo Besta Neurological Institute; Milan Italy
| | - Niccolò E. Mencacci
- Department of Neurology; Northwestern University, Feinberg School of Medicine; Chicago Illinois USA
| |
Collapse
|